Spectroscopic technique relying on the energy difference between the quantum spin states of electrons when exposed to an external magnetic field.
1Fasting serum lipoprotein number and size was determined by nuclear magnetic resonance.
2Structural characterization was performed by mass spectrometry and nuclear magnetic resonance analyses.
3Metabolites were quantified by nuclear magnetic resonance spectroscopy from fasting serum samples.
4Structural determinations were carried out by chemical analysis and nuclear magnetic resonance spectroscopy.
5The structures of the two compounds were confirmed by nuclear magnetic resonance data.
6Tumor energy metabolism was investigated in vivo by 31P nuclear magnetic resonance spectroscopy.
7Echocardiography and nuclear magnetic resonance imaging defined cardiac performance and structure.
8Circulating metabolites were quantified by high-throughput nuclear magnetic resonance metabolomics and biochemical assays.
9Thermal, chemical and structural properties were carried out using thermogravimetric analysis, nuclear magnetic resonance.
10The main outcomes were fasting serum lipoprotein subclasses determined by nuclear magnetic resonance analysis.
11Body composition of mice was analysed via nuclear magnetic resonance spectroscopy and microcomputed tomography.
12Hepatic glycogen concentrations were determined noninvasively using in vivo 13C nuclear magnetic resonance spectroscopy.
13Lipoprotein particle numbers were determined by nuclear magnetic resonance spectroscopy.
14Thus far, investigations have relied on traditional bioanalytic approaches including calorimetry or nuclear magnetic resonance.
15Patients with cardiac pacemakers are currently restricted from nuclear magnetic resonance imaging (MRI).
16Hepatic glycogen was assessed by natural abundance 13C nuclear magnetic resonance spectroscopy (MRS).
Translations for nuclear magnetic resonance